Potassium-Lowering Medication May Reduce Effectiveness of Other Medications
Potassium-Lowering Medication Drug Interactions. Concordia Pharmaceuticals has been directed by the Food and Drug Administration (FDA) to conduct studies of the potassium-lowering drug Kayexalate, because of the drug interactions that may reduce the effectiveness of other medications. Current label information for Kayexalate … [Read more...] about Potassium-Lowering Medication May Reduce Effectiveness of Other Medications
FDA Requires Drug Interaction Studies for Kayexalate
The Food and Drug Administration (FDA) is requiring the manufacturer of the potassium-lowering drug Kayexalate to conduct studies to investigate Kayexalate’s potential to affect how other medications work. The approved labeling for Kayexalate (sodium polystyrene sulfonate) describes its potential to decrease absorption of lithium … [Read more...] about FDA Requires Drug Interaction Studies for Kayexalate
